![Erik Skullerud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Skullerud
Keine laufenden Positionen mehr
Vermögen: 344 $ am 31.05.2024
Karriereverlauf von Erik Skullerud
Ehemalige bekannte Positionen von Erik Skullerud
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THOR MEDICAL | Vorstandsvorsitzender | 20.09.2021 | 26.08.2022 |
Amgen AB
![]() Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Vertrieb & Marketing | 01.09.2004 | 01.05.2016 |
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 01.01.1997 | 01.05.2000 |
Element Consulting GmbH | Gründer | 01.01.2017 | - |
Corporate Officer/Principal | 01.01.2017 | - |
Ausbildung von Erik Skullerud
Concordia University | Undergraduate Degree |
Handelshögskolan i Göteborg | Undergraduate Degree |
Statistik
International
Schweden | 3 |
Kanada | 2 |
Deutschland | 2 |
Operativ
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Amgen AB
![]() Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Health Technology |
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Element Consulting GmbH |
- Börse
- Insiders
- Erik Skullerud
- Erfahrung